Enzolytics, Inc. (OTCMKTS:ENZC) Short Interest Update

Enzolytics, Inc. (OTCMKTS:ENZC) was the target of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 662,300 shares, an increase of 331,050.0% from the January 31st total of 200 shares. Based on an average daily trading volume, of 15,741,500 shares, the short-interest ratio is currently 0.0 days.

Enzolytics Price Performance

Shares of Enzolytics stock opened at $0.00 on Friday. Enzolytics has a twelve month low of $0.00 and a twelve month high of $0.02.

About Enzolytics

Enzolytics Inc, a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy.